Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Bassler Bonnie L
Director at Regeneron Pharmaceuticals. Filing since 5 Jun 2020.
CIK 0001683607
Company
Date
Role
Action
Shares
Amount
Of holding
REGN
Regeneron Pharmaceuticals
7 Jan 2026
Director
Sold on a plan
1,500
$1.20M
46.8%
REGN
Regeneron Pharmaceuticals
20 Nov 2025
Director
Sold on a plan
760
$570.00K
32.9%
REGN
Regeneron Pharmaceuticals
15 Aug 2024
Director
Sold on a plan
756
$884.52K
35.4%
REGN
Regeneron Pharmaceuticals
2 Aug 2024
Director
Sold on a plan
756
$842.94K
35.4%
REGN
Regeneron Pharmaceuticals
24 Jun 2024
Director
Sold on a plan
756
$802.87K
35.4%
REGN
Regeneron Pharmaceuticals
5 Jun 2024
Director
Sold on a plan
827
$836.10K
37.4%
REGN
Regeneron Pharmaceuticals
26 Feb 2024
Director
Sold at will
854
$836.28K
38.2%
REGN
Regeneron Pharmaceuticals
30 Jan 2024
Director
Sold on a plan
827
$793.09K
37.4%
REGN
Regeneron Pharmaceuticals
3 Jan 2024
Director
Sold on a plan
826
$754.96K
37.4%
REGN
Regeneron Pharmaceuticals
13 Dec 2023
Director
Sold on a plan
610
$530.70K
32.8%
REGN
Regeneron Pharmaceuticals
21 Aug 2023
Director
Sold on a plan
853
$707.14K
40.6%
REGN
Regeneron Pharmaceuticals
10 Aug 2023
Director
Sold on a plan
853
$673.02K
40.6%
REGN
Regeneron Pharmaceuticals
24 Mar 2023
Director
Sold on a plan
1,240
$1.01M
49.9%
REGN
Regeneron Pharmaceuticals
3 Feb 2023
Director
Sold, plan not stated
1,021
$795.36K
45.0%
REGN
Regeneron Pharmaceuticals
8 Dec 2022
Director
Sold, plan not stated
218
$169.82K
16.8%
REGN
Regeneron Pharmaceuticals
9 Sep 2022
Director
Sold, plan not stated
609
$451.27K
36.0%
REGN
Regeneron Pharmaceuticals
8 Sep 2022
Director
Sold, plan not stated
2,558
$1.78M
70.3%
REGN
Regeneron Pharmaceuticals
7 Apr 2022
Director
Sold, plan not stated
1,240
$899.00K
53.4%
REGN
Regeneron Pharmaceuticals
30 Mar 2022
Director
Sold, plan not stated
1,240
$868.00K
53.4%
REGN
Regeneron Pharmaceuticals
16 Aug 2021
Director
Sold, plan not stated
1,219
$767.97K
57.8%
REGN
Regeneron Pharmaceuticals
5 Aug 2021
Director
Sold, plan not stated
2,559
$1.54M
74.2%
REGN
Regeneron Pharmaceuticals
1 Jul 2021
Director
Sold, plan not stated
2,558
$1.47M
74.2%
REGN
Regeneron Pharmaceuticals
19 Jun 2020
Director
Sold, plan not stated
2,559
$1.61M
79.9%
REGN
Regeneron Pharmaceuticals
5 Jun 2020
Director
Sold, plan not stated
2,559
$1.54M
79.9%
24 decisions on file.
